Neuralink Launches AI-Driven Brain-Computer Interface Trials in Canada

Thumbnail Image

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.

Neuralink, led by Elon Musk, has received Health Canada approval to begin its CAN-PRIME trial at Toronto Western Hospital, recruiting six quadriplegic patients. Neurosurgeons will use a robotic system to implant 1,024 AI-driven electrodes, assessing safety and initial functionality of the brain-computer interface for thought-controlled digital devices.[AI generated]

Why's our monitor labelling this an incident or hazard?

The event involves the use of an AI system (Neuralink's brain-computer interface decoding brain signals) in a clinical trial setting. While the system's development and use carry risks of physical harm (brain bleeds, infections) and potential privacy/security harms (hacking, thought insertion), no actual harm has been reported yet. The article discusses the start of patient recruitment and regulatory approval, highlighting possible complications and theoretical risks. Since no realized harm is described but plausible future harm exists, this fits the definition of an AI Hazard.[AI generated]
AI principles
SafetyRobustness & digital securityPrivacy & data governanceRespect of human rightsTransparency & explainabilityAccountabilityDemocracy & human autonomyHuman wellbeing

Industries
Healthcare, drugs, and biotechnologyRobots, sensors, and IT hardware

Harm types
Physical (injury)Physical (death)PsychologicalHuman or fundamental rights

Severity
AI hazard

Business function:
Research and developmentMonitoring and quality control

AI system task:
Recognition/object detectionOther


Articles about this incident or hazard